Fertility Clinic advertising on the Web: more Concerns about direct-to-Consumer Pharmaceutical Ads

What’s wrong with Fertility Clinics and Online Advertising

What’s Wrong With Fertility Clinics and Online AdvertisingDid you know the United States and New Zealand are the only nations that permit direct-to-consumer pharmaceutical ads?

Sadly, these clinic sites too often try to influence consumers with misleading information about their ability to create successful pregnancies.

DES Action USA commentd: ” Infertility plagued many DES Daughters and now there’s growing concern it may also be an issue for DES Granddaughters. Here’s fair warning about fertility clinic cute baby photos and glowing stats. Regulators are asleep at the switch on this type of advertising “.

Read What’s wrong with Fertility Clinics and Online Advertising.

Sources Direct-to-Consumer: Fertility Clinic Advertising on the Web.

Children born after In Vitro Fertilization at 33% higher Risk of Cancer

Fertility treatment and childhood cancer risk: a systematic meta-analysis

IVF Babies May Be at Higher Cancer RiskChildren born after in vitro fertilization (IVF) or other fertility treatments appear to be at modestly elevated risk of cancer, although causality still isn’t clear, a meta-analysis showed. ”

DES Info commented:  IVF is now very common and given the history with DES, there appears to be a linkage for cancer in this population. Research needed!

Read IVF Babies May Be at Higher Cancer Risk
by Crystal Phend, MedPage Today.


To clarify the association between fertility treatment and the risk for cancer in children.

Twenty-five cohort and case-control studies involving children born after fertility treatment as the exposure of interest and cancer as the outcome.

Main Outcome Measure(s)
Medline was searched through September 2012 to identify relevant studies. The study-specific estimates for each cancer outcome were combined into a pooled relative risk (RR) with 95% confidence interval (CI) by a meta-analytic approach.

We found that children born after fertility treatment were at increased risk for all cancers (RR = 1.33; 95% CI, 1.08–1.63) and for hematological cancers (RR = 1.59; 95% CI, 1.32–1.91), central nervous system/neural cancers (RR = 1.88; 95% CI, 1.02–3.46), and other solid cancers (RR = 2.19; 95% CI, 1.26–3.80). For specific cancer types, we found increased risks for leukemias (RR = 1.65; 95% CI, 1.35–2.01), neuroblastomas (RR = 4.04; 95% CI, 1.24–13.18), and retinoblastomas (RR = 1.62; 95% CI, 1.12–2.35) associated with fertility treatment.

The results of the largest meta-analysis on this topic to date indicate an association between fertility treatment and cancer in offspring. However, our results do not rule out that factors related to underlying subfertility, rather than the procedure itself, are the most important predisposing factors for childhood cancer.

Sources Fertility treatment and childhood cancer risk:
a systematic meta-analysis
, American Society for Reproductive Medicine, 2013.

Diclegis FDA approved to replace Bendectin as new Morning Sickness Drug

Another preventable future health tragedy?

#Diclegis is #FDA approved to replace #Bendectin as new Morning Sickness DrugA new pregnancy drug, the Diclegis® pill manufactured by  Duchesnay Inc. Canada, will enter pharmacies this June 2013.  This week (see tweet), in its news release, the FDA stated: ” The U.S. Food and Drug Administration today approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting “.

The “Morning Sickness Drug“, was called Bendectin between 1978 and 1983, and had over 300 lawsuits filed against the Merrell Dow pharmaceutical company, claiming damages for babies with deformities born to mothers who took the drug. The wide range of birth defects attributed to it were: limb and other musculoskeletal deformities; facial and brain damage; defects of the respiratory, gastrointestinal, cardiovascular and genital-urinary systems; blood disorders and cancer.

With many thanks to Judith Kavanaugh for warning me about this unbelievable but true news !!!

More information

The Push to Prescribe

Women and Canadian Drug Policy, by Anne Rochon Ford and Diane Saibil

The Push to prescribe: Women and Canadian Drug Policy, by Anne Rochon Ford and Diane Saibil on Flickr
The Push to prescribe: Women and Canadian Drug Policy, by Anne Rochon Ford and Diane Saibil.

In recent years, heated debate has surrounded the pharmaceutical industry and how it has gained unprecedented control over the evaluation, regulation, and promotion of its own products. As a result, drugs are produced, regulated, marketed, and used in ways that infiltrate many aspects of everyday life. The nature and extent of this infiltration, and how this has special meaning for women, are at the core of The Push to Prescribe.

The book delves into the world of prescription drugs in Canada, and considers the impact on the health of women. From the inadequate testing of many drugs on women in clinical trials, to the sometimes questionable portrayal of women in illegal prescription drug advertising, Canadian drug policy has not always paid attention to how women and men are affected differently.

This is an essential resource for a variety of courses in Health Sciences, Medicine, Nursing, Pharmacology, Public Policy, Public Health, Health Policy, Women’s Studies, Women’s Health, as well as many Social Science courses in areas like Sociology and Political Science. It will also be of interest to a general audience, health professional organizations, government health associations, and consumer and women’s groups.


  • presents an approach that combines compelling evidence with social, political, and gender-based analyses
  • discusses the complexity surrounding women and pharmaceuticals and uses the best evidence to argue for changes that better reflect women’s needs in public health policy and that ensure those who are best suited to make these determinations are included in policy-making


Quand l’Enfant se fait attendre

Blandine Maire est allée à la rencontre de quatre couples qui ne parviennent pas à avoir un bébé naturellement

Pour diverses raisons, comme le passé médical, l’âge toujours plus tardif auquel les femmes ont leur premier enfant, le mode de vie ou l’alimentation, les troubles de la fertilité sont plus fréquents qu’avant et représentent toujours une véritable angoisse pour les couples concernés. Pendant plusieurs mois, Blandine Maire a suivis quatre couples qui ne parviennent pas à avoir un bébé naturellement dans leur combat pour donner la vie. Entre doutes, espoirs, déceptions et intenses moments de joie, mais avec pudeur et honnêteté, tous ont accepté de partager leur aventure intime au quotidien.

  • Video publiée par france4
  • Diffusion ce mercredi 10/04/2013 à 22:25 et rediffusion jeudi 18/04/2013 à 23:25 sur France 4
  • La critique de Télérama
  • Notre Playlist de vidéos en français sur YouTube.

Bisphenol A leading to Fish inter-species breeding

Study revealed new Biodiversity Threat due to BPA

Hormone-Mimicking Chemicals Cause Inter-Species Mating: Bisphenol A Breaks Down Fish Species BarriersOur research shows how the presence of these humanmade chemicals leads to a greater likelihood of hybridization between species” concluded Dr Jessica Ward from the University of Minnesota, “This can have severe ecological and evolutionary consequences, including the potential for the decline of our native species.”

Read Hormone-Mimicking Chemicals Cause Inter-Species Mating: Bisphenol A Breaks Down Fish Species Barriers.


Environmental change can increase the likelihood of interspecific hybridization by altering properties of mate recognition and discrimination between sympatric congeners. We examined how exposure to an environmentally widespread endocrine-disrupting chemical (EDC), bisphenol A (BPA), affected visual communication signals and behavioral isolation between an introduced freshwater fish and a native congener (genus: Cyprinella). Exposure to BPA induced changes in the expression of male secondary traits as well as male and female mate choice, leading to an overall reduction in prezygotic isolation between congeners. Changes in female mate discrimination were not tightly linked to changes in male phenotypic traits, suggesting that EDC exposure may alter female choice thresholds independently of the effects of exposure on males. These findings indicate that environmental exposure to EDCs can lead to population declines via the erosion of species boundaries and by promoting the establishment and spread of non-native species via hybridization.

Sources : Exposure to an environmental estrogen breaks down sexual isolation between native and invasive species – Get PDF, 10 July 2012.

Anti-Depressants in Pregnancy: is there Evidence of Benefit?

Do antidepressant medications work the way they are supposed to?

Watch the webinar discussion  about women and Canadian drug policyAntidepressants are increasingly being used to treat depression in pregnancy in Canada despite their lack of approval for this use by Health Canada or the US FDA. Recent scientific and public attention has focused on an increased risk for infants, and this has led to conflicting advice about the use of SSRI/SNRI antidepressants (such as Prozac, Paxil, Effexor, or other related drugs) during pregnancy. Some suggest avoiding all exposures, while others recommend use in order to avoid harm to mothers and infants from untreated depression.

In 2009, Dr. Barbara Mintzes presented what she and colleagues found in a systematic evaluation of all available studies comparing women with depression who did or did not take antidepressants during pregnancy. Their goal was to find an answer to the controversial and urgent clinical question: do pregnant women benefit from taking antidepressants?

Watch the webinar discussion  about women and Canadian drug policy.

You watched the webinar? Please share your thoughts!

Regulate BPA out the Door !

Take Action against Chemicals that might harm your Family

Regulate BPA Out the Door, on Flickr
Cartoon by Danny Shanahan and published by Molly Rauch

Combined Net Profits for Top Global Pharmaceutical Companies, 2003-2012

Big Pharma Pockets $711 Billion in Profits by Robbing Seniors, Taxpayers

Big Pharma Pockets $711 Billion in Profits by Robbing Seniors, TaxpayersThe eleven largest global drug companies made an astonishing $711 billion in profits over the ten years ending in 2012.

In his post, Ethan Rome says: ” There are two reasons why it matters that the drug industry is booking eye-popping profits. First, American consumers and taxpayers are footing the bill, and second, we could do something about it. ‘

Read Big Pharma Pockets $711 Billion in Profits by Robbing Seniors, Taxpayers, huffingtonpost, 04/08/2013.